Top

BMC Complementary Medicine and Therapies

Published in:

Open Access 01-12-2014 | Research article

Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43

Authors: Shuyan Dai, Jingjing Liu, Xiaofei Sun, Ning Wang

Published in: BMC Complementary Medicine and Therapies | Issue 1/2014

Abstract

Background

Ganoderma lucidum (G. lucidum, Reishimax) is an herbal mushroom known to have inhibitory effect on tumor cell growth. However, the molecular mechanisms responsible for its anti-proliferative effects on the ovarian cancer have not been fully elucidated.

Methods

Human ovarian cancer cells HO 8910 (HOCC) and human primary ovarian cells (HPOC) were treated with G. lucidum. Effects of G. lucidum treatment on cell proliferation were studied by MTT assay. The expression of vascular endothelial growth factor (VEGF) and connexin 43 (Cx43) were measured by immunohistochemistry and real time polymerase chain reaction. To study the molecular mechanism of CX43 mediated anti-tumor activity, small interference RNA (siRNA) was used to knockdown Cx43 expression in HOCC.

Results

G. lucidum treatment resulted in reduced proliferation of HOCC. Inhibition of proliferation was accompanied by a decrease in VEGF expression and increase in Cx43 expression in the cancer cells. The extent of immune-reactivity of Cx43 or VEGF in cancer cells were correlated with the concentrations of G. lucidum used for treatment. Furthermore, knockdown of Cx43 expression in HOCC abrogated the effect of G. lucidum on cell proliferation without alteration of G. lucidum-induced attenuation of VEGF expression.

Conclusions

G. lucidum inhibits ovarian cancer by down-regulating the expression of VEGF and up-regulating the downstream Cx43 expression. G. lucidum may be a promising therapeutic agent for the treatment of ovarian cancer.

Available only for authorised users

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61 (2): 69-90. 10.3322/caac.20107.CrossRefPubMed

Wu GS, Guo JJ, Bao JL, Li XW, Chen XP, Lu JJ, Wang YT: Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review. Expert Opin Investig Drugs. 2013, 22 (8): 981-992. 10.1517/13543784.2013.805202.CrossRefPubMed

Hsieh T-C, Wu JM: Suppression of proliferation and oxidative stress 1 by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3. Int J Mol Med. 2011, 28 (6): 1065-1069.PubMed

Zhao S, Ye G, Fu G, Cheng J-X, Yang BB, Peng C: Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol. 2011, 38 (5): 1319-1327.PubMed

Santin A, Hermonat P, Ravaggi A, Cannon M, Pecorelli S, Parham G: Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol. 1999, 20 (3): 177-181.PubMed

Mesiano S, Ferrara N, Jaffe RB: Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am J pathol. 1998, 153 (4): 1249-1256. 10.1016/S0002-9440(10)65669-6.CrossRefPubMedPubMedCentral

Huang S, Robinson JB, DeGuzman A, Bucana CD, Fidler IJ: Blockade of nuclear factor-κB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res. 2000, 60 (19): 5334-5339.PubMed

Goodenough DA, Goliger JA, Paul DL: Connexins, connexons, and intercellular communication. Annu Rev Biochem. 1996, 65: 475-502. 10.1146/annurev.bi.65.070196.002355.CrossRefPubMed

Vinken M, de Kock J, Oliveira AG, Menezes GB, Cogliati B, Dagli ML, Vanhaecke T, Rogiers V: Modifications in connexin expression in liver development and cancer. Cell Commun Adhes. 2012, 19 (3–4): 55-62.CrossRefPubMed

10.

Sun Y, Zhao X, Yao Y, Qi X, Yuan Y, Hu Y: Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway. Int J Oncol. 2012, 41 (3): 941-948.PubMed

11.

Li Z, Zhou Z, Welch DR, Donahue HJ: Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis. 2008, 25 (8): 893-901. 10.1007/s10585-008-9208-9.CrossRefPubMedPubMedCentral

12.

Zhang YW, Kaneda M, Morita I: The gap junction-independent tumor-suppressing effect of connexin 43. J Biol Chem. 2003, 278 (45): 44852-44856. 10.1074/jbc.M305072200.CrossRefPubMed

13.

Corteggio A, Florio J, Roperto F, Borzacchiello G: Expression of gap junction protein connexin 43 in bovine urinary bladder tumours. J Comp Pathol. 2011, 144 (1): 86-90. 10.1016/j.jcpa.2010.05.002.CrossRefPubMed

14.

Umhauer S, Ruch RJ, Fanning J: Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma. Am J Obstet Gynecol. 2000, 182 (5): 999-1000. 10.1016/S0002-9378(00)70135-9.CrossRefPubMed

15.

Spinella F, Rosano L, Di Castro V, Nicotra MR, Natali PG, Bagnato A: Endothelin-1 decreases gap junctional intercellular communication by inducing phosphorylation of connexin 43 in human ovarian carcinoma cells. J Biol Chem. 2003, 278 (42): 41294-41301. 10.1074/jbc.M304785200.CrossRefPubMed

16.

Jou YS, Matesic D, Dupont E, Lu SC, Rupp HL, Madhukar BV, Oh SY, Trosko JE, Chang CC: Restoration of gap-junctional intercellular communication in a communication-deficient rat liver cell mutant by transfection with connexin 43 cDNA. Mol Carcinog. 1993, 8 (4): 234-244. 10.1002/mc.2940080406.CrossRefPubMed

17.

Pimentel RC, Yamada KA, Kléber AG, Saffitz JE: Autocrine regulation of myocyte Cx43 expression by VEGF. Circ Res. 2002, 90 (6): 671-677. 10.1161/01.RES.0000014823.75393.4D.CrossRefPubMed

18.

Iyer RK, Odedra D, Chiu LL, Vunjak-Novakovic G, Radisic M: Vascular endothelial growth factor secretion by nonmyocytes modulates Connexin-43 levels in cardiac organoids. Tissue Eng Part A. 2012, 18 (17–18): 1771-1783.CrossRefPubMedPubMedCentral

19.

Jiang J, Slivova V, Harvey K, Valachovicova T, Sliva D: Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer. 2004, 49 (2): 209-216. 10.1207/s15327914nc4902_13.CrossRefPubMed

20.

Loganathan J, Jiang J, Smith A, Jedinak A, Thyagarajan-Sahu A, Sandusky GE, Nakshatri H, Sliva D: The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes. Int J Oncol. 2014, 44 (6): 2009-2015.PubMedPubMedCentral

21.

Thyagarajan-Sahu A, Lane B, Sliva D: ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK. BMC Complement Altern Med. 2011, 11: 74-10.1186/1472-6882-11-74.CrossRefPubMedPubMedCentral

22.

Wang HH, Kung CI, Tseng YY, Lin YC, Chen CH, Tsai CH, Yeh HI: Activation of endothelial cells to pathological status by down-regulation of connexin43. Cardiovasc Res. 2008, 79 (3): 509-518. 10.1093/cvr/cvn112.CrossRefPubMed

23.

Peterson SM, Freeman JL: RNA isolation from embryonic zebrafish and cDNA synthesis for gene expression analysis. J Vis Exp. 2009, 30: 1470-PubMed

24.

Jayson GC, Kohn EC, Kitchener HC, Ledermann JA: Ovarian cancer. Lancet. 2014, 384 (9951): 1376-1388. 10.1016/S0140-6736(13)62146-7.CrossRefPubMed

25.

Kim HW, Won KS, Zeon SK, Ahn BC, Gayed IW: Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18 F-FDG PET/CT. Clin Nucl Med. 2013, 38 (2): 93-97. 10.1097/RLU.0b013e31826390ec.CrossRefPubMed

26.

Zytoon AA, Murakami K, Eid H, El-Gammal M: High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer. Acta Radiol. 2013, 54 (3): 340-348. 10.1258/ar.2012.120632.CrossRefPubMed

27.

Klostergaard J, Parga K, Raptis RG: Current and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management. P R Health Sci J. 2010, 29 (3): 223-231.PubMedPubMedCentral

28.

Diamandis EP: Mass spectrometry as a diagnostic and a cancer biomarker discovery tool opportunities and potential limitations. Mol Cell Proteomics. 2004, 3 (4): 367-378. 10.1074/mcp.R400007-MCP200.CrossRefPubMed

29.

Tekpli X, Rivedal E, Gorria M, Landvik NE, Rissel M, Dimanche-Boitrel MT, Baffet G, Holme JA, Lagadic-Gossmann D: The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis. Toxicol Appl Pharmacol. 2010, 242 (2): 231-240. 10.1016/j.taap.2009.10.012.CrossRefPubMed

30.

Li L, Wang L, Zhang W, Tang B, Zhang J, Song H, Yao D, Tang Y, Chen X, Yang Z, Wang G, Li X, Zhao J, Ding H, Reed E, Li QQ: Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res. 2004, 24 (3b): 1973-1979.PubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/434/prepub

Title: Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43
Authors: Shuyan Dai
Jingjing Liu
Xiaofei Sun
Ning Wang
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: BMC Complementary Medicine and Therapies / Issue 1/2014
Electronic ISSN: 2662-7671
DOI: https://doi.org/10.1186/1472-6882-14-434

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Internal health locus of control in users of complementary and alternative medicine: a cross-sectional survey

Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study

Protective effects of biochanin A on articular cartilage: in vitro and in vivo studies

In Vitro and In Vivo antifungal activities of selected Cameroonian dietary spices

Vernonia amygdalina simultaneously suppresses gluconeogenesis and potentiates glucose oxidation via the pentose phosphate pathway in streptozotocin-induced diabetic rats

Chlorophytum borivilianum (Safed Musli) root extract prevents impairment in characteristics and elevation of oxidative stress in sperm of streptozotocin-induced adult male diabetic Wistar rats